Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Evaluation of Outpatient Prescription Patterns of Covid-19 Drugs in Iran: Comparison of Real Practice With Local Therapeutic Recommendations Publisher

Summary: A study found many COVID-19 drugs were misused in Iran, highlighting need for better treatment guidelines. #COVID19 #Healthcare

Zargarzadeh AH1 ; Abdi Z2 ; Mousavi S1
Authors

Source: Journal of Pharmaceutical Policy and Practice Published:2023


Abstract

Background: A comprehensive guideline named “Diagnostic Therapeutic Flow Chart for Covid-19″ (DTFC) was released by the Scientific Committee of Covid-19 of Iran’s Ministry of Health and Medical Education and regularly was updated. The aim of this study was to compare the prescription pattern of drug treatment in outpatient Covid-19 patients with the DTFC. Methods: A cross-sectional study was conducted on the prescription pattern of drugs given to outpatients with a diagnosis of Covid-19, in Isfahan City from June to September 2021 (concurrent with the fifth peak of Covid-19 in Iran) taking into account the recommendations of the 9th version of DTFC (December 2020). A total of 8250 prescriptions were retrieved from the Public Health Department of Isfahan City. Results: Famotidine 20, 40 mg tablets (N = 936 patients) was the most prescribed drug followed by dexamethasone ampule (N = 588), prednisolone 5, 50 mg tablets (N = 478), azithromycin 250, 500 mg capsules (N = 452), diphenhydramine syrup (N = 362), vitamin D3 soft gel 50,000 Iu (N = 526), naproxen 250, 500 mg tablets (N = 266) and favipiravir 200 mg tablet (N = 191). The following drugs were administered against the recommendation of the DTFC-9: azithromycin, favipiravir, remdesivir, cetirizine, corticosteroids, vitamin C, vitamin B12, multivitamins, proton pump inhibitors (e.g., omperazole, anticoagulants (rivaroxaban,….), aspirin and ivermectin. Administration of analgesics, famotidine, hydroxychloroquine, vitamin D3, diphenhydramine and statins were in concordance with the DTFC-9. Conclusion: In this study, we showed frequent use of drugs with unproven efficacy in outpatient cases of Covid-19 mostly attributed to corticosteroids and antibiotics use. Our research highlights the discrepancy between recommendations for care and clinical practice and the need for strategy to bridge gaps in evidence-based informed decision-making. © 2023, The Author(s).
Related Docs
View other Related Docs
1. Efficacy of Persian Medicine Herbal Formulations (Capsules And Decoction) Compared to Standard Care in Patients With Covid-19, a Multicenter Open-Labeled, Randomized, Controlled Clinical Trial, Phytotherapy Research (2021)
2. Epidemiological Status and Health System Screening of Covid 19 Hospitalized Patients in Isfahan, Iran, Medical Journal of the Islamic Republic of Iran (2022)
3. Intravenous Methylprednisolone Pulse As a Treatment for Hospitalised Severe Covid-19 Patients: Results From a Randomised Controlled Clinical Trial, European Respiratory Journal (2020)
Experts (# of related papers)
View all Related Experts
Ramin Sami (3)
Fereshteh Ashtari (2)
Evaluation of Outpatient Prescription Patterns of Covid-19 Drugs in Iran: Comparison of Real Practice With Local Therapeutic Recommendations
Other Related Docs
4. Drug Repositioning Approach to Target Viral and Host Cells in Terms of Covid-19 Treatment: A Review of in Vivo Experiments and Clinical Studies, Journal of Experimental and Clinical Medicine (Turkey) (2022)
5. A Review of Pathophysiological Mechanism, Diagnosis, and Treatment of Thrombosis Risk Associated With Covid-19 Infection, IJC Heart and Vasculature (2022)
6. Association of the Medication Protocols and Longitudinal Change of Covid-19 Symptoms: A Hospital-Based Mixed-Statistical Methods Study, Journal of Biopharmaceutical Statistics (2024)
7. An Investigation on Patient Attitudes Toward Package Inserts and Their Accessibility in Iran, Journal of Research in Medical Sciences (2018)
8. Drug-Related Hospital Admissions in a Generic Pharmaceutical System, Clinical and Experimental Pharmacology and Physiology (2007)
9. Characteristics of Covid-19 in Patients With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2022)
10. Prescribing Quality in Medical Specialists in Isfahan, Iran, Iranian Journal of Pharmaceutical Research (2013)
11. The Impact of Covid-19 Pandemic on Neuromyelitis Optica Disorder Patients, After One Year, Caspian Journal of Neurological Sciences (2022)
12. Clinical Signs, Symptoms, and Severity of Covid-19 in Patients With Rheumatic Diseases During the Covid-19 Epidemic, Immunopathologia Persa (2024)
13. Drug Prescription Patterns and Compliance With Who and Beers Criteria in Older Patients, BMC Geriatrics (2025)
14. Severity of Disease and Covid-19 Complications During Hospital Stay: A Prospective Cohort Study, Archives of Iranian Medicine (2022)
15. The Role of Hydroxychloroquine in Covid-19 Treatment: A Systematic Review and Meta-Analysis, Annals of the Academy of Medicine Singapore (2020)
16. Comparison of the Effect of Intravenous Dexamethasone and Methylprednisolone on the Treatment of Hospitalized Patients With Covid-19: A Randomized Clinical Trial, International Journal of Infectious Diseases (2022)
17. Effects of Curcumin-Piperine Co-Supplementation on Clinical Signs, Duration, Severity, and Inflammatory Factors in Patients With Covid-19: A Structured Summary of a Study Protocol for a Randomised Controlled Trial, Trials (2020)
18. The Effect of Vitamin E and Vitamin C in Patients With Covid-19 Pneumonia; a Randomized Controlled Clinical Trial, Immunopathologia Persa (2022)
19. Investigating Methods for Coronavirus Disease 2019 Control: A Systematic Review, Polish Annals of Medicine (2021)
20. Effect of Covid-19 Medications on Corrected Qt Interval and Induction of Torsade De Pointes: Results of a Multicenter National Survey, International Journal of Clinical Practice (2021)